Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suremom is an oral maternal nutrition nutraceutical marketed by Kaviva for use during pregnancy and lactation, with positioning for prenatal and postnatal nutritional support and supportive use in IVF or fertility contexts where maternal dietary intake may be suboptimal. The product is a finished protein supplement based primarily on whey and casein protein and is described as containing approximately 20 essential nutrients together with added ingredients such as shatavari, jivanti, vitamins, minerals, amino acids, and docosahexaenoic acid. Its functional mechanism is nutritional rather than receptor-targeted: it supplies dietary protein and micronutrients intended to support maternal protein requirements, metabolism, energy, and overall nutritional status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Suremom.